1.76
price up icon0.00%   0.00
 
loading
Beyondspring Inc stock is traded at $1.76, with a volume of 26,529. It is up +0.00% in the last 24 hours and down -5.88% over the past month. BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
See More
Previous Close:
$1.76
Open:
$2.0205
24h Volume:
26,529
Relative Volume:
0.44
Market Cap:
$70.98M
Revenue:
$1.88M
Net Income/Loss:
$-15.57M
P/E Ratio:
-4.40
EPS:
-0.4
Net Cash Flow:
$-50.09M
1W Performance:
-12.87%
1M Performance:
-5.88%
6M Performance:
-1.68%
1Y Performance:
-7.12%
1-Day Range:
Value
$1.74
$2.0205
1-Week Range:
Value
$1.72
$2.05
52-Week Range:
Value
$0.98
$3.44

Beyondspring Inc Stock (BYSI) Company Profile

Name
Name
Beyondspring Inc
Name
Phone
646-528-4184
Name
Address
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Name
Employee
40
Name
Next Earnings Date
2024-08-05
Name
Latest SEC Filings
Name
BYSI's Discussions on Twitter

Compare BYSI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
BYSI
Beyondspring Inc
1.76 74.61M 1.88M -15.57M -50.09M -0.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Beyondspring Inc Stock (BYSI) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-21 Downgrade BofA Securities Buy → Underperform
Dec-02-21 Downgrade Jefferies Buy → Hold
Dec-01-21 Downgrade H.C. Wainwright Buy → Neutral
Dec-01-21 Downgrade William Blair Outperform → Mkt Perform
Sep-09-21 Initiated Robert W. Baird Outperform
Aug-04-21 Upgrade H.C. Wainwright Neutral → Buy
Apr-05-21 Downgrade H.C. Wainwright Buy → Neutral
Jan-11-21 Initiated BofA Securities Buy
Dec-29-20 Initiated Evercore ISI Outperform
Feb-07-20 Initiated Jefferies Buy
Jan-10-20 Initiated Nomura Buy
Dec-03-19 Initiated William Blair Outperform
Jul-10-19 Reiterated H.C. Wainwright Buy
Apr-30-19 Downgrade Maxim Group Buy → Hold
Oct-25-18 Reiterated Maxim Group Buy
View All

Beyondspring Inc Stock (BYSI) Latest News

pulisher
Aug 20, 2025

Candlestick signals on BeyondSpring Inc. stock todayWeekly Profit Summary & Risk Managed Investment Strategies - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What MACD and RSI say about BeyondSpring Inc.Market Performance Report & Weekly Sector Rotation Insights - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Chart overlay techniques for tracking BeyondSpring Inc.Analyst Downgrade & Consistent Return Strategy Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will BeyondSpring Inc. benefit from macro trendsInflation Watch & Target Return Focused Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Institutional scanner results for BeyondSpring Inc.2025 Top Gainers & Technical Confirmation Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Real time scanner hits for BeyondSpring Inc. explainedMarket Sentiment Summary & Weekly Momentum Stock Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

BeyondSpring (NASDAQ:BYSI) Releases Quarterly Earnings Results - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

What recovery options are there for BeyondSpring Inc.Inflation Watch & Long Hold Capital Preservation Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Custom watchlist performance reports with BeyondSpring Inc.2025 Performance Recap & Community Verified Watchlist Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Visual trend scoring systems applied to BeyondSpring Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Should you wait for a breakout in BeyondSpring Inc.Trade Risk Assessment & Smart Allocation Stock Tips - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Market reaction to BeyondSpring Inc.’s recent newsGap Down & Low Risk Growth Stock Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using economic indicators to assess BeyondSpring Inc. potentialWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Statistical indicators supporting BeyondSpring Inc.’s strengthOptions Play & Free Community Supported Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Has BeyondSpring Inc. found a price floorJuly 2025 Highlights & Growth Oriented Trade Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using fundamentals and technicals on BeyondSpring Inc.Trade Ideas & Weekly High Momentum Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to manage a losing position in BeyondSpring Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

BeyondSpring Inc. stock volume spike explainedJuly 2025 Drop Watch & Intraday High Probability Alerts - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Applying chart zones and confluence areas to BeyondSpring Inc.Market Volume Report & Daily Entry Point Trade Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

BeyondSpring (NASDAQ:BYSI) Shares Down 2%Time to Sell? - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Heatmap analysis for BeyondSpring Inc. and competitorsWeekly Earnings Recap & Weekly Return Optimization Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Analyzing net buyer seller activity in BeyondSpring Inc.2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will a bounce in BeyondSpring Inc. offer an exitJuly 2025 Drop Watch & Free Weekly Watchlist of Top Performers - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

BeyondSpring Reports Promising Clinical Results for Plinabulin in NSCLC Patients and Improved Q2 2025 Financials - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

BeyondSpring Q2 2025: Promising Clinical Results and Strategic Moves - AInvest

Aug 16, 2025

Beyondspring Inc Stock (BYSI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Beyondspring Inc Stock (BYSI) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Decheng Capital China Life Sci
10% Owner
Aug 19 '25
Sale
1.77
3,604
6,379
1,922,900
Decheng Capital China Life Sci
10% Owner
Aug 20 '25
Sale
1.74
3,456
6,013
1,919,444
Decheng Capital China Life Sci
10% Owner
Aug 15 '25
Sale
2.00
2,900
5,800
1,974,172
Decheng Capital China Life Sci
10% Owner
Aug 14 '25
Sale
2.00
2,000
4,000
1,977,072
Decheng Capital China Life Sci
10% Owner
Jun 20 '25
Sale
3.15
285,217
898,286
935,000
Decheng Capital China Life Sci
10% Owner
Jun 18 '25
Sale
3.17
59,253
187,832
1,844,326
Decheng Capital China Life Sci
10% Owner
Jul 17 '25
Sale
2.19
20,572
45,053
894,830
Decheng Capital China Life Sci
10% Owner
Jul 08 '25
Sale
2.29
9,059
20,745
925,017
Decheng Capital China Life Sci
10% Owner
Jun 17 '25
Sale
3.23
5,000
16,150
995,000
Decheng Capital China Life Sci
10% Owner
Jul 16 '25
Sale
2.24
5,396
12,087
915,402
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):